Metabolic Syndrome and Breast Cancer Molecular Subtypes: An Observational Patient Study

Metabolic Syndrome and Breast Cancer Molecular Subtypes: An Observational Patient Study

Background: Breast cancer molecular subtypes share various prognostic profiles, and luminal A molecular subtypes have a better prognosis compared with other molecular subtypes. However, whether metabolic syndrome or individual risk factors of metabolic syndrome influence on the development of molecu...

Bibliografski detalji
Glavni autori:	Dafina Ademi-Islami, Suzana Manxhuka-Kerliu, Dhurata Tarifa-Koroveshi, Rozafa Koliqi, Blerim Mujaj
Format:	Članak
Jezik:	English
Izdano:	SAGE Publishing 2022-03-01
Serija:	Breast Cancer: Basic and Clinical Research
Online pristup:	https://doi.org/10.1177/11782234221080555

Slični predmeti

Comparative Accuracy of Mammography and Ultrasound in Women with Breast Symptoms According to Age and Breast Density
od: Emine Devolli-Disha, i dr.
Izdano: (2009-05-01)

The Prognostic Role of Vascular Endothelial Growth Factor-A Expression in Thyroid Carcinomas
od: Vela-Gaxha Zana, i dr.
Izdano: (2019-03-01)

Evaluation of breast symptoms with mammography and ultrasonography
od: Emine Devolli Disha, i dr.
Izdano: (2011-12-01)

Colorectal Cancer: Prognostic Values
od: Suzana Manxhuka-Kerliu, i dr.
Izdano: (2009-02-01)

Radiographic estimation in seropositive and seronegative rheumatoid arthritis
od: Vjollca Sahatçiu-Meka, i dr.
Izdano: (2011-08-01)

Extra-Articular Manifestations of Seronegative and Seropositive Rheumatoid Arthritis
od: Vjollca Sahatçiu-Meka, i dr.
Izdano: (2010-02-01)

VDR Immunohistochemistry Expression Is Down-Regulated in Colorectal Cells of Patients with IBD and Could Rank the Patients According to Their Complications Risk
od: Argjira Juniku-Shkololli, i dr.
Izdano: (2023-08-01)

Forty-Five Years of Research and Progress in Breast Cancer: Progress for Some, Disparities for Most
od: Ilir Hoxha, i dr.
Izdano: (2022-03-01)

In Vitro Examination of Degenerative Evolution of Adrenergic Nerve Endings in Pulmonary Inflamatory Processes in Newborns
od: Hilmi Islami, i dr.
Izdano: (2008-08-01)

Clear cell variant of diffuse large B-cell lymphoma: a case report
od: Sahatciu-Meka Vjollca, i dr.
Izdano: (2011-05-01)

Clinical Significance of VEGF-A and Microvessel Density in Diffuse Large B-Cell Lymphoma and Low-Grade Follicular Lymphoma
od: Labinot Shahini, i dr.
Izdano: (2017-01-01)

Breast Cancer Disease Burden in Albania
od: Anila Pema (Kristo), i dr.
Izdano: (2022-07-01)

In Vitro Examination of Ontogenesis of Developing Neuronal Cells in Vagal Nuclei in Medulla Oblongata in Newborns
od: Hilmi Islami, i dr.
Izdano: (2008-11-01)

Prognostic Values of Thyroid Tumours
od: Suzana Manxhuka-Kerliu, i dr.
Izdano: (2009-05-01)

Hepatobiliary neuroendocrine carcinoma: a case report
od: Loxha Sadushe, i dr.
Izdano: (2010-02-01)

Electrophysiological and functional evaluation of peroneal nerve regeneration in rabbit following topical hyaluronic acid or tacrolimus application after nerve repair
od: Agon Y Mekaj, i dr.
Izdano: (2015-01-01)

Cytofluorometric characteristics of molecular subtypes of breast cancer
od: L. K. Tsoi, i dr.
Izdano: (2014-08-01)

Ultrasonography: an aid in molecular subtyping of breast carcinoma
od: Thakur Shruti, i dr.
Izdano: (2025-01-01)

Immunophenotypic features of molecular subtypes of breast cancer
od: S.V. Chulkova, i dr.
Izdano: (2022-10-01)

S100 protein in molecular subtypes of breast cancer
od: Ecaterina Carpenco
Izdano: (2020-10-01)

Network Modularity in Breast Cancer Molecular Subtypes
od: Sergio Antonio Alcalá-Corona, i dr.
Izdano: (2017-11-01)

Molecular subtypes and imaging phenotypes of breast cancer
od: Nariya Cho
Izdano: (2016-10-01)

Characteristics, Effect of Histological Grade and Localization on the Prognosis of Colorectal Cancer. A retrospective Study.
od: Enkelejda Çuedari, i dr.
Izdano: (2022-07-01)

Salivary Tryptophan as a Metabolic Marker of HER2-Negative Molecular Subtypes of Breast Cancer
od: Elena A. Sarf, i dr.
Izdano: (2024-04-01)

Quantitative assessment of metabolic tumor burden in molecular subtypes of primary breast cancer with FDG PET/CT
od: Wei Chen, i dr.
Izdano: (2018-11-01)

Molecular Subtypes of Breast Carcinoma and Their Association with Clinicopathological Features
od: Ambreen Bari, i dr.
Izdano: (2025-01-01)

The Landscape of Breast Cancer Molecular and Histologic Subtypes in Canada
od: Anna N. Wilkinson, i dr.
Izdano: (2024-09-01)

Predictors of molecular subtypes in women with breast cancer in Rwanda
od: F. Ntirenganya, i dr.
Izdano: (2022-12-01)

Breast Carcinoma: Correlation of Molecular Subtypes with Histopathologic Characteristics
od: Clement Wilfred Devadass, i dr.
Izdano: (2023-12-01)

Multiparametric MRI Features of Breast Cancer Molecular Subtypes
od: Madalina Szep, i dr.
Izdano: (2022-11-01)

«Salivaomics» of Different Molecular Biological Subtypes of Breast Cancer
od: Lyudmila V. Bel’skaya, i dr.
Izdano: (2022-07-01)

Predictors of molecular subtypes in women with breast cancer in Rwanda
od: F. Ntirenganya, i dr.
Izdano: (2023-01-01)

Utility of MRI in diagnosis of molecular subtypes of breast cancer
od: Ebtsam Ahmed Mohammed*, i dr.
Izdano: (2022-01-01)

Metaplastic breast cancer: Treatment and prognosis by molecular subtype
od: Jin Hu, i dr.
Izdano: (2021-05-01)

Cancer Metabolic Subtypes and Their Association with Molecular and Clinical Features
od: Moiso, Enrico, i dr.
Izdano: (2022)

Cancer Metabolic Subtypes and Their Association with Molecular and Clinical Features
od: Moiso, Enrico, i dr.
Izdano: (2022)

Biomechanical and Macroscopic Evaluations of the Effects of 5-Fluorouracil on Partially Divided Flexor Tendon Injuries in Rabbits
od: Shkelzen B Duci, i dr.
Izdano: (2015-06-01)

Protocol for performing metabolic pathway-based subtyping of breast tumors
od: Mohammad Askandar Iqbal, i dr.
Izdano: (2024-09-01)

Breast Cancer Subtypes Underlying EMT-Mediated Catabolic Metabolism
od: Eunae Sandra Cho, i dr.
Izdano: (2020-09-01)

Molecular Subtypes of Breast Cancer Are Not Associated with the Clinical Under- or Overstaging of Breast Cancer
od: Juliana Pinho Espinola, i dr.
Izdano: (2016-05-01)